OOIR: Observatory of International Research

Papers

(The median citation count of Seminars in Immunopathology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Learning cell identity in immunology, neuroscience, and cancer	150
Micro-to multi-chimerism: the multiple facets of a singular phenomenon	125
Complement & disease: out of the shadow into the spotlight	117
Vascular galectins in tumor angiogenesis and cancer immunity	114
Halting targeted and collateral damage to red blood cells by the complement system	112
Adaptive immunity, chronic inflammation and the clock	99
Role of polyamines in intestinal mucosal barrier function	95
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16	92
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors	76
Diseases of blood vessels: Immune system involvement in vasculitis and vasculopathy	73
Regulatory T lymphocytes as a therapy for ischemic stroke	69
Genetics and functional genomics of multiple sclerosis	56
The mucosal immune system and IgA nephropathy	54
Immune checkpoint for pregnancy	52
Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	49
Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation	46
IgA glycosylation and immune complex formation in IgAN	46
Correction to: Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation	46
Thromboinflammatory challenges in stroke pathophysiology	44
Genetics of rheumatoid arthritis	41
The role of vaccines in the COVID-19 pandemic: what have we learned?	41
The emerging role of complement in neuromuscular disorders	41
Publisher Correction: Epithelial recognition and elimination against aberrant cells	40
Towards multiomic analysis of oral mucosal pathologies	38
The duality of microchimerism and cancer in parous women: a review and evolutionary perspective	37

Cap analysis of gene expression (CAGE) and noncoding regulatory elements	37
Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries	37
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation	36
Immunization of preterm infants: current evidence and future strategies to individualized approaches	35
Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus	35
Are there animal models of IgA nephropathy?	35
The molecular mechanisms of inflammation and scarring in the kidneys of immunoglobulin A nephropathy	33
Glucocorticoid circadian rhythms in immune function	33
The role of microglia in early neurodevelopment and the effects of maternal immune activation	33
Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis	33
Tolerance and autoimmunity in the liver	32
IgA nephropathy: a perspective for 2021	31
TNF in the liver: targeting a central player in inflammation	29
Current treatment of IgA nephropathy	29
Single-cell RNA-seq methods to interrogate virus-host interactions	29
Dyslipidemia and female reproductive failures: perspectives on lipid metabolism and endometrial immune dysregulation	28
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy	27
CAF-immune cell crosstalk and its impact in immunotherapy	27
Correction to: MAIT cells in liver inflammation and fibrosis	26
The aging immune system in Alzheimer’s and Parkinson’s diseases	26
Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection	25
Revisiting transplant immunology through the lens of single-cell technologies	25
Unveiling the immunopathology of stroke: a comprehensive view on brain-immune interaction	24
Beyond defence: Immune architects of ovarian health and disease	24
Tissue-resident immunity in the female and male reproductive tract	24
Arginine metabolism in myeloid cells in health and disease	24
CAR T-cell behavior and function revealed by real-time imaging	24
Eosinophils and helminth infection: protective or pathogenic?	22
Local anesthetics and immunotherapy: a novel combination to fight cancer	22
Circadian regulation of innate immunity in animals and humans and implications for human disease	22
Role of bile acids in inflammatory liver diseases	22
B cells in autoimmune hepatitis: bystanders or central players?	21
Complement activation in IgA nephropathy	21
Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women	21
Complement in metabolic disease: metaflammation and a two-edged sword	20
Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers	20
Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition	20
Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)	20
Immune compartments at the brain’s borders in health and neurovascular diseases	19
Correction to: Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target	19
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment	19
Correction to: Complement in ischaemia–reperfusion injury and transplantation	19
Functional interrogation of autoimmune disease genetics using CRISPR/Cas9 technologies and massively parallel reporter assays	19
Harnessing the liver to induce antigen-specific immune tolerance	18
How genetic risk contributes to autoimmune liver disease	18
Role of alarmins in poststroke inflammation and neuronal repair	17
Intertwining roles of circadian and metabolic regulation of the innate immune response	17
Tipping the balance: intricate roles of the complement system in disease and therapy	17
Role of glia and extracellular matrix in controlling neuroplasticity in the central nervous system	16
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells	16

Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy	16
Gut microbiota-derived metabolites tune host homeostasis fate	16
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease	16
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology	15
Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers	15
Proteomics to study cancer immunity and improve treatment	14
The role of circulating cell-free DNA as an inflammatory mediator after stroke	14
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke	14
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells	14
Tumor microenvironment antigens	14
Circadian rhythms in adaptive immunity and vaccination	14
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity	13
The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells	13
Mechanisms of vascular damage in ANCA vasculitis	13
Intracellular galectin interactions in health and disease	13
Cell therapies for viral diseases: a new frontier	13
The microbiome and IgA nephropathy	12
Role of Hyaluronic acid and its chemical derivatives in immunity during homeostasis, cancer and tissue regeneration	12
The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation	12
Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism	12
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment	12
Heterogeneity of tissue-resident immunity across organs and in health and disease	12
Physiological and immunological barriers in the lung	12